VERU Stock Summary and Trading Ideas (Veru | NASDAQ:VERU)

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology and acute respiratory distress syndrome (ARDS). The company is also in the late stage development of certain drugs for management of breast and prostate cancers. It also has a sexual health program which includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in single segment and generates revenue from USA which is the key revenue generating market, South Africa and other regions.

Veru trades on the NASDAQ stock market under the symbol VERU.

As of May 17, 2024, VERU stock price declined to $1.32 with 1,539,537 million shares trading.

VERU has a beta of 0.14, meaning it tends to be less sensitive to market movements. VERU has a correlation of 0.00 to the broad based SPY ETF.

VERU has a market cap of $193.10 million. This is considered a Micro Cap stock.

Last quarter Veru reported $4 million in Revenue and -$.07 earnings per share. This beat revenue expectation by $1 million and missed earnings estimates by -$.02.

In the last 3 years, VERU stock traded as high as $24.55 and as low as $.36.

The top ETF exchange traded funds that VERU belongs to (by Net Assets): VTI, VXF, IWC, AVSC.

VERU has underperformed the market in the last year with a price return of +15.8% while the SPY ETF gained +29.1%. However, in the short term, VERU had mixed performance relative to the market. It has outperformed in the last 3 months, returning +172.8% vs +6.3% return in SPY. But in the last 2 weeks, VERU shares have been beat by the market, returning -19.0% compared to an SPY return of +3.6%.

VERU support price is $1.27 and resistance is $1.48 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that VERU stock will trade within this expected range on the day.